United Kingdom

People: Yield10 Bioscience Inc (YTEN.OQ)

YTEN.OQ on NASDAQ Stock Exchange Capital Market

20 Aug 2019
Change (% chg)

$-0.00 (-0.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Peoples, Oliver 

Dr. Oliver P. Peoples,(Olly) Ph.D. is a President, Chief Executive Officer, Director of the Company. He is co-founder of Metabolix, has served as our chief scientific officer since January 2000 and was previously our vice president of research and development. Dr. Peoples has served as a director since June 1992. Before founding Metabolix, Dr. Peoples was a research scientist with the Department of Biology at MIT. The research carried out by Dr. Peoples at MIT established the fundamental tools and methods for engineering bacteria and plants to produce polyhydroxyalkanoates. Dr. Peoples received a Ph.D. in Molecular Biology from the University of Aberdeen, Scotland. The Board believes that Dr. Peoples provides important technical and scientific understanding to the Board's analysis of Company strategy. As Chief Scientific Officer and a founder of the Company, Dr. Peoples has unique information related to the Company's research and technology and has led and directed many of our scientific research and development programs. Dr. Peoples also contributes to the Board's understanding of the intellectual property aspects of the Company's technology platforms.

Basic Compensation

Total Annual Compensation, USD 384,000
Restricted Stock Award, USD 396,900
Long-Term Incentive Plans, USD --
All Other, USD 11,925
Fiscal Year Total, USD 792,825

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --